Is non-contrast-enhanced magnetic resonance imaging cost-effective for screening of hepatocellular carcinoma?

Is non-contrast-enhanced magnetic resonance imaging cost-effective for screening of hepatocellular carcinoma?

Ultrasonography (US) is the current standard of care for imaging surveillance in patients at risk of hepatocellular carcinoma (HCC). Magnetic resonance imaging (MRI) has been explored as an alternative, given the higher sensitivity of MRI, although this comes at a higher cost. We performed a cost-ef...

Full description

Saved in:
Bibliographic Details
Main Authors: Tan, Genevieve Jingwen, Lee, Chau Hung, Sun, Yan, Tan, Cher Heng
Other Authors: Lee Kong Chian School of Medicine (LKCMedicine)
Format: Article
Language:English
Published: 2024
Subjects:
Medicine, Health and Life Sciences
Cost‑effectiveness analysis
Ultrasound surveillance
Online Access:https://hdl.handle.net/10356/178556
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-178556
record_format dspace
spelling sg-ntu-dr.10356-1785562024-06-30T15:39:30Z Is non-contrast-enhanced magnetic resonance imaging cost-effective for screening of hepatocellular carcinoma? Tan, Genevieve Jingwen Lee, Chau Hung Sun, Yan Tan, Cher Heng Lee Kong Chian School of Medicine (LKCMedicine) Medicine, Health and Life Sciences Cost‑effectiveness analysis Ultrasound surveillance Ultrasonography (US) is the current standard of care for imaging surveillance in patients at risk of hepatocellular carcinoma (HCC). Magnetic resonance imaging (MRI) has been explored as an alternative, given the higher sensitivity of MRI, although this comes at a higher cost. We performed a cost-effective analysis comparing US and dual-sequence non-contrast-enhanced MRI (NCEMRI) for HCC surveillance in the local setting. Published version 2024-06-26T01:50:30Z 2024-06-26T01:50:30Z 2024 Journal Article Tan, G. J., Lee, C. H., Sun, Y. & Tan, C. H. (2024). Is non-contrast-enhanced magnetic resonance imaging cost-effective for screening of hepatocellular carcinoma?. Singapore Medical Journal, 65(1), 23-29. https://dx.doi.org/10.11622/smedj.2021153 0037-5675 https://hdl.handle.net/10356/178556 10.11622/smedj.2021153 34628803 2-s2.0-85182388849 1 65 23 29 en Singapore Medical Journal © 2024 Singapore Medical Journal | Published by Wolters Kluwer - Medknow. This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution‑NonCommercial‑ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non‑commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic Medicine, Health and Life Sciences
Cost‑effectiveness analysis
Ultrasound surveillance
spellingShingle Medicine, Health and Life Sciences
Cost‑effectiveness analysis
Ultrasound surveillance
Tan, Genevieve Jingwen
Lee, Chau Hung
Sun, Yan
Tan, Cher Heng
Is non-contrast-enhanced magnetic resonance imaging cost-effective for screening of hepatocellular carcinoma?
description Ultrasonography (US) is the current standard of care for imaging surveillance in patients at risk of hepatocellular carcinoma (HCC). Magnetic resonance imaging (MRI) has been explored as an alternative, given the higher sensitivity of MRI, although this comes at a higher cost. We performed a cost-effective analysis comparing US and dual-sequence non-contrast-enhanced MRI (NCEMRI) for HCC surveillance in the local setting.
author2 Lee Kong Chian School of Medicine (LKCMedicine)
author_facet Lee Kong Chian School of Medicine (LKCMedicine)
Tan, Genevieve Jingwen
Lee, Chau Hung
Sun, Yan
Tan, Cher Heng
format Article
author Tan, Genevieve Jingwen
Lee, Chau Hung
Sun, Yan
Tan, Cher Heng
author_sort Tan, Genevieve Jingwen
title Is non-contrast-enhanced magnetic resonance imaging cost-effective for screening of hepatocellular carcinoma?
title_short Is non-contrast-enhanced magnetic resonance imaging cost-effective for screening of hepatocellular carcinoma?
title_full Is non-contrast-enhanced magnetic resonance imaging cost-effective for screening of hepatocellular carcinoma?
title_fullStr Is non-contrast-enhanced magnetic resonance imaging cost-effective for screening of hepatocellular carcinoma?
title_full_unstemmed Is non-contrast-enhanced magnetic resonance imaging cost-effective for screening of hepatocellular carcinoma?
title_sort is non-contrast-enhanced magnetic resonance imaging cost-effective for screening of hepatocellular carcinoma?
publishDate 2024
url https://hdl.handle.net/10356/178556
_version_ 1806059870704631808

Similar Items